EcoR1 Capital’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$863K Buy
+64,303
New +$958K 0.04% 35

Other funds holding CTNM

EcoR1 Capital's CTNM Position: Q3 2026 in Review

EcoR1 Capital opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 64,303 shares worth $863K. The stake represents 0.04% of the portfolio and ranks #35 among its holdings.

115 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • EcoR1 Capital held 64,303 shares of Contineum Therapeutics worth $863K as of Q3 2026.
  • Contineum Therapeutics was a new EcoR1 Capital position in Q3 2026.
  • Contineum Therapeutics made up 0.04% of EcoR1 Capital's portfolio in Q3 2026, its #35 holding.
  • 115 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on EcoR1 Capital's 13F filing for Q3 2026, filed 16 Nov 2026.